BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fortinguerra S, Sorrenti V, Giusti P, Zusso M, Buriani A. Pharmacogenomic Characterization in Bipolar Spectrum Disorders. Pharmaceutics 2019;12:E13. [PMID: 31877761 DOI: 10.3390/pharmaceutics12010013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Anmella G, Vilches S, Espadaler-Mazo J, Murru A, Pacchiarotti I, Tuson M, Garriga M, Solé E, Brat M, Fico G, Vieta E. Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression. Genes (Basel) 2021;12:1259. [PMID: 34440433 DOI: 10.3390/genes12081259] [Reference Citation Analysis]
2 Zhang P, Kong L, Huang H, Pan Y, Zhang D, Jiang J, Shen Y, Xi C, Lai J, Ng CH, Hu S. Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder. Front Neurosci 2022;16:830748. [DOI: 10.3389/fnins.2022.830748] [Reference Citation Analysis]
3 Hussen BM, Abdullah ST, Salihi A, Sabir DK, Sidiq KR, Rasul MF, Hidayat HJ, Ghafouri-Fard S, Taheri M, Jamali E. The emerging roles of NGS in clinical oncology and personalized medicine. Pathol Res Pract 2022;230:153760. [PMID: 35033746 DOI: 10.1016/j.prp.2022.153760] [Reference Citation Analysis]
4 Iannaccone T, Sellitto C, Manzo V, Colucci F, Giudice V, Stefanelli B, Iuliano A, Corrivetti G, Filippelli A. Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters. Pharmaceuticals (Basel) 2021;14:204. [PMID: 33804537 DOI: 10.3390/ph14030204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]